Page last updated: 2024-08-26

bosentan anhydrous and Nerve Degeneration

bosentan anhydrous has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braine, CE; Howell, GR; John, SW; Macalinao, DG; MacNicoll, KH; Soto, I; Sousa, GL	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Nerve Degeneration

Article	Year
Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. Neurobiology of disease, 2014, Volume: 71 Topics: Animals; Astrocytes; Bosentan; Complement C1q; Disease Models, Animal; Endothelial Cells; Endothelin A Receptor Antagonists; Endothelin-2; Glaucoma; Humans; Mice; Mice, Inbred DBA; Nerve Degeneration; Pyrimidines; Receptor, Endothelin A; Retinal Ganglion Cells; Sulfonamides	2014

Article

Year

Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.

Neurobiology of disease, 2014, Volume: 71

Topics: Animals; Astrocytes; Bosentan; Complement C1q; Disease Models, Animal; Endothelial Cells; Endothelin A Receptor Antagonists; Endothelin-2; Glaucoma; Humans; Mice; Mice, Inbred DBA; Nerve Degeneration; Pyrimidines; Receptor, Endothelin A; Retinal Ganglion Cells; Sulfonamides

2014